BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 21, 2005
View Archived Issues
Zadaxin shows dose-dependent response in combination with DTIC with and without low-dose interferon
Read More
Increased GABA-A alpha1 subunit reduced status epilepticus in rats by 50%
Read More
Passiflora incarnata might contain anticonvulsive ingredients
Read More
Update on clinical study of tefibazumab
Read More
Clinical study of STA-5326 for psoriasis
Read More
Novartis to consider acquiring Berna Biotech
Read More
Innogenetics reviews diagnostics and therapeutics businesses
Read More
Advisory Committee reviews Zostavax
Read More
Eisai resubmits corrected Aricept sNDA
Read More
FDA lifts clinical hold on phase I study of CB-001
Read More
Voluntary suspension of sales, marketing and distribution of NeutroSpec
Read More
FDA rules BioThrax is safe and effective to prevent anthrax
Read More
Phase III study of tifacogin in severe CAP cleared to continue
Read More
Ethics approval for study of MPL-TLB100
Read More
Results from cell line study of Factor 5A in multiple myeloma
Read More
Urocortin 2 demonstrates positive effects on cardiac output and blood pressure
Read More
Remodulin effective in improving six-minute walk distance in PAH patients
Read More
No significant increase in time to neurologic progression in Xcytrin study
Read More
Astellas discloses data on a novel parenteral cephalosporin
Read More
BC-2901: Novel broad-spectrum cephem-azomethine
Read More
WQ-3335: Novel fluoroquinolone with high efficacy against mutated S. pneumoniae
Read More
BLX-1060 -- potential for IBD
Read More
New treatments for urological disorders claimed in recent Tanabe Seiyaku and Eisai patents
Read More
New antiinfective compounds revealed
Read More
Prostanoid EP4 agonists for ocular disorders emerge from Merck Frosst R&D
Read More
TLK-199 induces responses in myelodysplastic syndrome patients
Read More
CEP-701 enhances chemotherapy for FLT3 mutation acute myelogenous leukemia
Read More
New data on AMG-531 in immune thrombocytopenic purpura reported
Read More
SGN-30 evaluated in phase II studies in lymphoma patients
Read More